Investing in Maternal Anemia: Six Priorities for Policymakers

Maternal Anemia Control: What Health Policymakers Can DoTo catalyze and invigorate global awareness and action toward reducing maternal anemia, this brief identifies feasible, scalable, and evidence-based maternal anemia control interventions, and the policy actions that will facilitate their quality implementation.

With an eye toward policymakers, donor and international organizations, national governments and NGOs, this brief emphasizes the need for the integration of not only iron folic acid (IFA) supplementation, but also malaria, hookworm, and family planning interventions. It presents six concise priorities for policymakers: political commitment, program integration, supply management, enhanced community roles, increased demand, and strong systems for program monitoring and evaluation.

Despite its significance to public health and overall development, maternal anemia control is often a low priority on the health agenda. Reducing anemia in women will decrease the risk of maternal and perinatal mortality, improve cognitive development in children, and increase physical capacity and work productivity in adults, enabling achievement of Millennium Development Goals 4 and 5.

This brief is a product of the ongoing collaboration between A2Z and MCHIP, and was designed to create an opportunity for dialogue with and between health policymakers. For more information on A2Z’s work in maternal anemia, please visit For information on MCHIP’s work in maternal anemia, visit

Click here to view the brief.

Click here to view Maternal Anemia Resources.